MondayFeb 22, 2021 12:47 pm

XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Advances Rapid COVID Test System, Expands Psychedelic Medicine Programs

Life sciences industry accelerator XPhyto Therapeutics Corp. has developed a timeline for the approval and rollout of a rapid, portable COVID-19 test it expects to become available by April in Europe XPhyto’s Covid-ID Lab system is designed to help industries economically devastated by the pandemic to form strategies based on quick and accurate testing, particularly the travel industry The company intends to use its test tech partnership with Germany’s 3a-diagnostics GmbH to build additional bacteriological and viral testing products A separate subsidiary based in Alberta is developing psychedelic medicine programs The subsidiary recently announced it has added mescaline production to…

Continue Reading

MondayFeb 22, 2021 12:15 pm

Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) Closer to Pure Mushrooms Sales with Company Code, NPN Submission

PULL recently received Company Code from Canada’s Natural and Non-prescription Health Products Directorate Code allows PULL to submit application to sell its first functional mushroom product Company intends to submit additional NPN applications during 2021 as part of larger strategy to develop portfolio of functional mushroom wellness products Functional mushrooms, those that provide a health benefit beyond just nutrition, are growing in popularity worldwide amid an accelerating trend to fend off viruses with immune-boosting food and drinks. Looking to seize part of a global functional mushroom market forecast by Data Bridge Market Research to hit $555.9 billion by 2028, Pure…

Continue Reading

FridayFeb 19, 2021 11:37 am

Ryah Group Inc. Making Digital Transformation in the Lab a Reality

Company has completed steps necessary to achieve, sustain competitive advantage in move towards remote-health solutions and trials RYAH technology optimizes patient feedback so medical trials, studies can move into remote solution zones Recently developed an integrated, customized mobile application to support a major clinical study in the United Kingdom RYAH created cloud of stored data to help with R&D of future medical treatments RYAH Group, a leading digital health-care analytics and technology company, is on a mission to advance the world’s transition to remote-health solutions and data analytics in patient treatments. The company believes that, when patients are given more…

Continue Reading

ThursdayFeb 18, 2021 10:03 am

Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Enters Large Cannabis Biomass Agreements to Scale Up Extract Production, Announces DTC Eligibility of Common Shares in the U.S.

Pure Extracts entered into two large biomass purchase agreements, plans to ramp up production of high-potency THC and CBD extracts in 2021 Company expects historically low biomass purchase price will produce $590,000 revenue Company recently announced DTC eligibility of common shares for increased settlement and clearance speeds, wider access to brokerage firms Pure Extracts Technologies (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ), a plant-based extraction company that focuses on cannabis, hemp, functional mushrooms and the rapidly emerging psychedelics sector, recently entered into two substantial cannabis biomass purchase agreements (https://cnw.fm/XYzBs) in addition to announcing that its common shares are now eligible for electronic clearing…

Continue Reading

WednesdayFeb 17, 2021 2:09 pm

Pac Roots Cannabis Corp. (CSE: PACR) (OTCQB: PACRF) Leverages Genetics to Produce Potent CBD Strains Amid New Research Suggesting CBD Aids COVID-19 Patients

Austrian researchers report CBD reduces inflammation and speeds recovery in ICU COVID-19 patients Research suggests CBD’s anti-inflammatory properties stave off long-term neurological damage associated with COVID-19 PACR leverages genetic technology to produce potent CBD strains with higher yields per growing season Company catalog includes 350 cultivars and 50 super-elite strains prized in industry CBD may soon become the newest support in the world’s fight against COVID-19: Researchers at the Klagenfurt Clinic in Austria recently reported positive results from cannabidiol (“CBD”) trials on COVID-19 patients that demonstrated reduced inflammation and quicker recovery times (https://cnw.fm/gUeyW). Pac Roots Cannabis (CSE: PACR) (OTCQB: PACRF), a Canada-based…

Continue Reading

WednesdayFeb 17, 2021 1:49 pm

CannAssist International Corp. (CNSC) Focused on Leveraging Position in Growing Cannabis Industry through Strategic Marketing Plan

Vast opportunities exist in growing cannabis space CannAssist is committed to establishing aggressive marketing presence in promising market CannAssist brings impressive advancements, achievements to the table, including its propriety CiBiDinol technology Carefully developing and executing a strategic go-to-market plan has never been more important for companies operating in the cannabis industry, according to a recent “Rolling Stone” article (https://cnw.fm/uMoi5). The article urges cannabis companies to consider the industry from both a competitive perspective as well as an opportunity angle, which is exactly what CannAssist International (OTCQB: CNSC) has done as it looks toward 2021 and a projected $5.8 million share of the…

Continue Reading

FridayFeb 12, 2021 2:55 pm

Grapefruit USA Inc. (GPFT) Rolls Out Hourglass by Grapefruit in Greater Los Angeles; Poised to Sustain Rapid Growth

Grapefruit expands availability of patented Hourglass by Grapefruit(TM) product to Greater Los Angeles area Hourglass is manufactured only at Grapefruit's Coachillin facility, available only through Grapefruit authorized retailers GPFT achieved robust growth in 2020, poised to continue momentum going forward as demand remains strong Grapefruit USA (OTCQB: GPFT), a premier fully licensed California-based company, has announced that its patented Hourglass time-release THC+Cannabinoid infused topical delivery cream has been rolled out to additional licensed retail cannabis locations in the Greater Los Angeles area (https://cnw.fm/DruVP). Hourglass is manufactured exclusively at Grapefruit's Coachillin facility and available only through Grapefruit authorized retailers. The company has…

Continue Reading

WednesdayFeb 10, 2021 2:29 pm

HempFusion Wellness Inc. (TSX: CBD.U) (OTC: CBDHF) (FWB: 8OO) Begins 2021 Strong with OTC Market Listing, New Product, and USDA Organic Certification

HempFusion Wellness Inc. is currently in the process of applying for OTCQX listing and DTC eligibility after a swift and strategic move to enter the OTC Pink Market under the ticker symbol ‘CBDHF’ Wholly owned subsidiary Probulin Probiotics recently released Total Care Immune probiotic, which is expected to reach retailer shelves in February 2021 Probulin is recognized as one of the fastest-growing probiotic brands in the American Natural Products Industry January, HempFusion received USDA Organic Certification for its CBD tinctures In a strategic move to broaden the United States investor audience, health and wellness company HempFusion Wellness (TSX: CBD.U) (OTC:…

Continue Reading

TuesdayFeb 09, 2021 2:36 pm

Pac Roots Cannabis Corp. (CSE: PACR) (OTCQB: PACRF) Private Placement to Raise Funds for Continued Successful Operations

PACR private placement comprised of 8,333,333 units for possible gross proceeds of $1.5 million Funding to support Company’s continued progress in current, potential efforts An example of Pac Roots projects includes JV with Rock Creek Farms, which resulted in profitable first harvest that delivered 200% ROI Pac Roots Cannabis (CSE: PACR) (OTCQB: PACRF) has announced a non-brokered private placement (https://cnw.fm/9VKYf) to strengthen its financial position as it focuses on the future of genetics and its commitment to quality over quantity. Headquartered in Canada, Pac Roots is dedicated to producing premium-quality strains and products by leveraging a genetics-focused approach. The announcement of the private placement…

Continue Reading

MondayFeb 08, 2021 12:36 pm

2021 Strategic Plan Showcases API Potential of XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT)

XPhyto Therapeutics Corp. is a life sciences technology accelerator involved in the development of new pharmaceuticals, diagnostic products and psychedelic investments XPhyto is preparing a series of clinical pilot studies for four drug candidates this year that could help in treating Parkinson’s disease, epilepsy, anorexia and other neurological conditions The company has developed a rapid and highly portable PCR test kit it expects to commercialize this year to provide point-of-care diagnostics, designed for satellite labs to quickly screen for the COVID-19 virus Wholly owned subsidiary Vektor, a German drug maker and researcher, plans to build a new commercial drug manufacturing…

Continue Reading

CBDWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 303.498.7722